1 No-Brainer Healthcare Vanguard ETF to Buy Right Now for Less Than $1,000

Source The Motley Fool

Key Points

  • Expected increased capital spending and the implementation of artificial intelligence (AI) are structural tailwinds for healthcare stocks today.

  • Spending is expected to be 20% of GDP by 2032.

  • The Vanguard Healthcare ETF (VHT) is my favorite ETF in this sector due to its expansive coverage in companies of all sizes.

  • 10 stocks we like better than Vanguard World Fund - Vanguard Health Care ETF ›

Healthcare is a sector that's about as durable as they come. Everybody continually needs medicine, doctor's visits, and medical equipment. That makes it a sector with steady, sustained demand regardless of the economic environment.

It's not exciting though, which is why the sector has underperformed lately. No one wants boring when artificial intelligence (AI) stocks are rocketing higher.

Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »

But conditions are changing. The economy is slowing, recession fear is growing, and the geopolitical backdrop adds another wild card to the mix.

If you've got cash sitting on the sidelines right now, there's a compelling case to put it to work in the Vanguard Healthcare ETF (NYSEMKT: VHT), one of my favorite funds in this space.

Stethoscope on top of dollar bills.

Image source: Getty Images.

Key takeaways

  • VHT includes roughly 400 stocks from an all-cap U.S. stock universe, making it ideal for broad sector coverage.
  • Healthcare has lagged the S&P 500 over the past several years as investors have focused heavily on tech and growth stocks.
  • The aging of America and integration of AI into the sector remain key long-term catalysts.
  • Healthcare is traditionally one of the best-performing sectors during market downturns.

Why healthcare makes sense right now

From a structural standpoint, the healthcare sector has one of the most resilient demand profiles in the global economy. The need for medical care, prescription drugs, and health services is constant. In an economy where consumer spending capacity is shrinking, growth is slowing, and inflation is rising, the kind of profile makes sense as a defensive component to a portfolio.

The sector is also benefiting from increased capital spending. Many hospitals and facilities are in the very early stages of weaving AI into their workflows. Medical equipment and facilities need upgrading. The latest medical equipment needs to be purchased and implemented.

As a result, healthcare spending is projected to increase to $7.7 trillion by 2032, which would amount to nearly 20% of gross domestic product (GDP).

What makes VHT better than other healthcare ETFs?

The natural comparison for the Vanguard Healthcare ETF is the State Street Health Care Select Sector SPDR ETF (NYSEMKT: XLV).

Metric VHT XLV
Expense ratio 0.09% 0.08%
Number of holdings 410 59
Market cap coverage Large, mid, small Mostly large
One-year return 14% 10.9%
Five-year return (avg.) 5.2% 6.4%
Dividend yield (approx.) 1.4% 1.7%
AUM $17.7 billion $38.5 billion
Best use case Broad sector coverage Large-cap focus

Sources: Vanguard, State Street

When investing in a more narrow, thematic sector, I prefer something more concentrated to make it as pure play as possible. When investing in a core economic sector, however, I prefer broad and diversified investments.

The Vanguard Healthcare ETF targets companies of all sizes, not just the big ones. Longer-term performance has lagged that of the State Street Health Care Select Sector SPDR ETF, but that's a byproduct of the market's recent focus on large caps. Over time, I'd expect to see the small-cap portion of the Vanguard fund's portfolio to help enhance returns.

Given the undervalued nature of healthcare sector stocks and the slowing U.S. economy, this ETF makes a lot of sense for your next investment.

Should you buy stock in Vanguard World Fund - Vanguard Health Care ETF right now?

Before you buy stock in Vanguard World Fund - Vanguard Health Care ETF, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vanguard World Fund - Vanguard Health Care ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $555,526!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,156,403!*

Now, it’s worth noting Stock Advisor’s total average return is 968% — a market-crushing outperformance compared to 191% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of April 13, 2026.

David Dierking has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Bitcoin CME gaps at $35,000, $27,000 and $21,000, which one gets filled first?Prioritize filling the $27,000 gap and even try higher.
Author  FXStreet
Aug 22, 2023
Prioritize filling the $27,000 gap and even try higher.
placeholder
Pinduoduo Earnings Incoming: Morgan Stanley Sees Long-Term Profit Potential​Insights – On November 21, Chinese e-commerce giant Pinduoduo (PDD) will release its Q3 2024 earnings.
Author  Mitrade
Nov 20, 2024
​Insights – On November 21, Chinese e-commerce giant Pinduoduo (PDD) will release its Q3 2024 earnings.
placeholder
Elon Musk’s xAI and Neuralink Launch New Funding Rounds​Billionaire Elon Musk recently raised funds for his two high-profile tech companies, xAI and Neuralink.
Author  Insights
Jun 03, 2025
​Billionaire Elon Musk recently raised funds for his two high-profile tech companies, xAI and Neuralink.
placeholder
Bitcoin briefly loses 2025 gains as crypto plunges over the weekend.Bitcoin experienced a sharp decline this weekend, briefly erasing its 2025 gains and dipping below its year-opening value of $93,507. The cryptocurrency fell to a low of $93,029 on Sunday, representing a 25% drop from its all-time high in October. Although it has rebounded slightly to around $94,209, the pressures on the market remain significant. The downturn occurred despite the reopening of the U.S. government on Thursday, which many had hoped would provide essential support for crypto markets. This year initially appeared promising for cryptocurrencies, particularly after the inauguration of President Donald Trump, who has established the most pro-crypto administration thus far. However, ongoing political tensions—including Trump's tariff strategies and the recent government shutdown, lasting a historic 43 days—have contributed to several rapid price pullbacks for Bitcoin throughout the year. Market dynamics are also being influenced by Bitcoin whales—investors holding large amounts of Bitcoin—who have been offloading portions of their assets, consequently stalling price rallies even as positive regulatory developments emerge. Despite these sell-offs, analysts from Glassnode argue that this behavior aligns with typical patterns seen among long-term investors during the concluding stages of bull markets, suggesting it is not indicative of a mass exodus. Notably, Bitcoin is not alone in its struggles, as Ethereum and Solana have also recorded declines of 7.95% and 28.3%, respectively, since the start of the year, while numerous altcoins have faced even steeper losses. Looking ahead, questions linger regarding the viability of the four-year cycle thesis, particularly given the increasing institutional support and regulatory frameworks now in place in the crypto landscape. Matt Hougan, chief investment officer at Bitwise, remains optimistic, suggesting a potential Bitcoin resurgence in 2026 driven by the “debasement trade” thesis and a broader trend toward increased adoption of stablecoins, tokenization, and decentralized finance. Hougan emphasized the soundness of the underlying fundamentals, pointing to a positive outlook for the sector in the longer term.
Author  Mitrade
Nov 17, 2025
Bitcoin experienced a sharp decline this weekend, briefly erasing its 2025 gains and dipping below its year-opening value of $93,507. The cryptocurrency fell to a low of $93,029 on Sunday, representing a 25% drop from its all-time high in October. Although it has rebounded slightly to around $94,209, the pressures on the market remain significant. The downturn occurred despite the reopening of the U.S. government on Thursday, which many had hoped would provide essential support for crypto markets. This year initially appeared promising for cryptocurrencies, particularly after the inauguration of President Donald Trump, who has established the most pro-crypto administration thus far. However, ongoing political tensions—including Trump's tariff strategies and the recent government shutdown, lasting a historic 43 days—have contributed to several rapid price pullbacks for Bitcoin throughout the year. Market dynamics are also being influenced by Bitcoin whales—investors holding large amounts of Bitcoin—who have been offloading portions of their assets, consequently stalling price rallies even as positive regulatory developments emerge. Despite these sell-offs, analysts from Glassnode argue that this behavior aligns with typical patterns seen among long-term investors during the concluding stages of bull markets, suggesting it is not indicative of a mass exodus. Notably, Bitcoin is not alone in its struggles, as Ethereum and Solana have also recorded declines of 7.95% and 28.3%, respectively, since the start of the year, while numerous altcoins have faced even steeper losses. Looking ahead, questions linger regarding the viability of the four-year cycle thesis, particularly given the increasing institutional support and regulatory frameworks now in place in the crypto landscape. Matt Hougan, chief investment officer at Bitwise, remains optimistic, suggesting a potential Bitcoin resurgence in 2026 driven by the “debasement trade” thesis and a broader trend toward increased adoption of stablecoins, tokenization, and decentralized finance. Hougan emphasized the soundness of the underlying fundamentals, pointing to a positive outlook for the sector in the longer term.
placeholder
My Top 5 Stock Market Predictions for 2026Five 2026 market predictions written in a native, news-style voice: AI’s winners and losers, broader sector leadership, dividend demand, valuation cooling as the Shiller CAPE sits at 39 (Dec. 31, 2025), and quantum-computing bursts—while keeping all original facts and numbers unchanged.
Author  Mitrade
Jan 06, Tue
Five 2026 market predictions written in a native, news-style voice: AI’s winners and losers, broader sector leadership, dividend demand, valuation cooling as the Shiller CAPE sits at 39 (Dec. 31, 2025), and quantum-computing bursts—while keeping all original facts and numbers unchanged.
goTop
quote